Status:

Red

Decision Date:

March 2019

Comments

RED^1,2,3:NICE TA575: treating moderate to severe plaque psoriasis. (Decision date - May 2019)

Red Drug Classifications

• 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
• 2: Requiring long term on-going monitoring of efficacy by a specialist and not suitable for shared care
• 3: Requiring long term on-going monitoring of toxicity by a specialist (either because of difficulty in recognising side effects or high cost of investigations to identify toxicity)

search again